Knowledge about tuberculosis, treatment adherence and outcome among ambulatory patients with drug-sensitive tuberculosis in two directly-observed treatment centres in Southwest Nigeria
Date
2021
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Background: Tuberculosis (TB) remains one of the most common infectious diseases worldwide. Although TB is
curable provided the treatment commenced quickly, appropriately and uninterrupted throughout TB treatment
duration. However, high default rate, treatment interruption and therapy non-adherence coupled with inadequate
disease knowledge significantly contribute to poor TB treatment outcome, especially in developing countries. This
study therefore assessed knowledge about TB and possible reasons for treatment non-adherence among drugsensitive
TB (DS-TB) patients, as well as evaluated treatment outcomes for the DS-TB managed within a 5-year
period.
Methods: A mixed-method design comprising a cross-sectional questionnaire-guided survey among 140-ambulatory
DS-TB patients from January–March 2019, and a retrospective review of medical-records of DS-TB managed from 2013
to 2017 in two WHO-certified TB directly-observed-treatment centres. Data were summarized using descriptive
statistics, while categorical variables were evaluated with Chi-square at p < 0.05.
Results: Among the prospective DS-TB patients, males were 77(55.0%) and females were 63(45.0%). Most (63;45.0%)
belonged to ages 18-34 years. A substantial proportion knew that TB is curable (137;97.9%) and transmittable (128;
91.4%), while 107(46.1%) accurately cited coughing without covering the mouth as a principal mode of transmission.
Only 10(4.0%) mentioned adherence to TB medications as a measure to prevent transmission. Inaccessibility to
healthcare facility (33;55.0%) and pill-burden (10,16.7%) were topmost reasons for TB treatment non-adherence. Of the
2262-DS-TB patients whose treatment outcomes were evaluated, 1211(53.5%) were cured, 580(25.6%) had treatment
completed, 240(10.6%) defaulted, 54(2.3%) failed treatment and 177(7.8%) died. Overall, the treatment success rate
within the 5-year period ranged from 77.4 to 81.9%.
Description
Keywords
: Drug-sensitive tuberculosis || Directly observed treatment short-course || Knowledge || Treatment outcome || Nigeria
Citation
BMC Public Health 2021; Pp. 21:677